Vaccine-Preventable Diseases

Vaccine-preventable diseases are communicable infections for which a safe and effective vaccine exists, so that their occurrence can be reduced — and in some cases eliminated or eradicated — through immunisation. In global health they are a defining success story and a continuing equity challenge: the same vaccines that have driven down measles, polio, and other infections remain unevenly available across the world's populations.

Definition

Vaccine-preventable diseases are infectious diseases against which a licensed, effective vaccine is available, such that immunisation can prevent disease in vaccinated individuals and reduce transmission in the population.

Scope

The topic covers the diseases addressed by established vaccines, the population-level mechanisms by which immunisation protects individuals and communities, and the programmatic and equity dimensions of delivering vaccines worldwide. It is reference-educational and does not provide schedules, dosing, or individual immunisation advice, which are set by clinical guidelines and national programmes.

Core questions

• Which communicable diseases can be prevented by vaccination?
• How does immunisation protect both the vaccinated individual and the surrounding community?
• What is herd immunity, and what coverage is needed to interrupt transmission?
• Why does the burden of vaccine-preventable disease persist despite available vaccines?

Key concepts

• Active and passive immunisation
• Vaccine efficacy and effectiveness
• Herd immunity threshold
• Immunisation coverage
• Elimination and eradication
• Cold chain and delivery
• Vaccine hesitancy and equity

Key theories

Herd immunity

When a sufficient fraction of a population is immune, the chains of transmission are interrupted and even unvaccinated individuals gain indirect protection; the threshold rises with the pathogen's transmissibility, linking immunisation coverage to population-level control.

Mechanisms

Vaccines present the immune system with antigens — attenuated or inactivated organisms, subunits, toxoids, or genetic templates — so that protective immune memory develops without the disease. At the population level, immunising a large enough share of susceptible people lowers the effective reproduction number and can interrupt transmission, conferring indirect protection on those not immune; the coverage needed for this herd-immunity effect increases with the pathogen's transmissibility. Realising these benefits depends on effective vaccines, functioning delivery systems including the cold chain, and sustained, equitable coverage.

Clinical relevance

The concept frames why immunisation programmes are a cornerstone of preventive public health and how coverage gaps translate into outbreaks of diseases such as measles. This entry describes the population logic of vaccine-preventable disease and is reference-educational; immunisation decisions for individuals follow current clinical guidelines and national schedules, which are outside its scope.

Epidemiology

Vaccination has produced some of the largest reductions in communicable-disease mortality, including the eradication of smallpox and dramatic declines in measles, diphtheria, pertussis, tetanus, and invasive bacterial disease where coverage is high. Substantial burden persists, concentrated in populations with low or interrupted coverage, and outbreaks recur where immunity falls below the herd-immunity threshold, keeping equitable delivery a central global-health priority.

History

Deliberate immunisation traces from variolation and Jenner's smallpox vaccine through the bacteriological era's toxoids and inactivated vaccines to the expansion of childhood immunisation in the twentieth century. The launch of coordinated global immunisation programmes and the eradication of smallpox established vaccination as a flagship public-health intervention, while later decades broadened the range of preventable diseases and sharpened attention to coverage and equity.

Debates

How should programmes respond to vaccine hesitancy and falling coverage?

Maintaining herd immunity requires sustained high coverage, but confidence, access, and complacency vary across communities, and the balance of communication, policy, and service measures needed to keep coverage above outbreak thresholds is debated.

Key figures

• Stanley Plotkin
• Walter Orenstein
• Paul Fine
• David Heymann

Seminal works

• andre-2008
• fine-2011
• plotkin-2018

Frequently asked questions

What does it mean for a disease to be 'vaccine-preventable'?

It means a safe and effective vaccine exists against the causative agent, so that immunisation can prevent the disease in vaccinated individuals and, at sufficient coverage, reduce its spread in the population.

Why do vaccine-preventable diseases still occur?

Because the benefit depends on coverage: where immunisation is interrupted by access barriers, supply problems, conflict, or hesitancy, the share of immune people can fall below the threshold needed to block transmission, and outbreaks return.